Abstract:BACKGROUND & AIMS: Gut microbiota have been reported to be sensitive to circadian rhythms and host lipometabolism, respectively. Although melatonin-mediated beneficial efforts on many physiological sites have been revealed, the regulatory actions of oral melatonin on the communication between gut microbiota and host are still not clear. Angiopoietin-like 4 (ANGPTL4) has been shown to be strongly responsible for the regulation of systemic lipid metabolism. Herein, we identified that oral melatonin improved lipid dysmetabolism in ileum and epididymal white adipose tissue (eWAT) via gut microbiota and ileac ANGPTL4. METHODS: Analyses of jet-lag (JL) mice, JL mice with oral melatonin administration (JL+MT), and the control for mRNA and protein expression regarding lipid uptake and accumulation in ileum and eWAT were made. Gut microbiome sequencing and experimental validation of target strains were included. Functional analysis of key factors/pathways in the various rodent models, including the depletion of gut microbiota, mono-colonization of Escherichia coli, and other genetic intervention was made. Analyses of transcriptional regulation and effects of melatonin on E coli-derived lipopolysaccharide (LPS) in vitro were made. RESULTS: JL mice have a higher level of ileal lipid uptake, fat accumulation in eWAT, and lower level of circulating ANGPTL4 in comparison with the control mice. JL mice also showed a significantly higher abundance of E coli and LPS than the control mice. Conversely, oral melatonin supplementation remarkably reversed these phenotypes. The test of depletion of gut microbiota further demonstrated that oral melatonin-mediated improvements on lipometabolism in JL mice were dependent on the presence of gut microbiota. By monocolonization of E coli, LPS has been determined to trigger these changes similar to JL. Furthermore, we found that LPS served as a pivotal link that contributed to activating toll-like receptor 4 (TLR4)/signal transducer and activator of transcription 3 (STAT3_/REV-ERB alpha) signaling to up-regulate nuclear factor interleukin-3-regulated protein (NFIL3) expression, resulting in increased lipid uptake in ileum. In MODE-K cells, the activation of NFIL3 has further been shown to inhibit ANGPTL4 transcription, which is closely associated with lipid uptake and transport in peripheral tissues. Finally, we confirmed that melatonin inhibited LPS via repressing the expression of LpxC in E coli. CONCLUSIONS: Overall, oral melatonin decreased the quantity of E coli-generated LPS, which alleviated NFIL3-induced transcriptional inhibition of ANGPTL4 through TLR4/IL-22/STAT3 signaling in ileum, thereby resulting in the amelioration of ileal lipid intake and lower fat accumulation in eWAT. These results address a novel regulation of oral melatonin originating from gut microbiota to host distal tissues, suggesting that microbe-generated metabolites are potential therapies for melatonin-mediated improvement of circadian rhythm disruption and related metabolic syndrome.

Melatonin Orchestrates Lipid Homeostasis through the Hepatointestinal Circadian Clock and Microbiota during Constant Light Exposure

Ambient Fine Particulate Matter Disrupts Hepatic Circadian Oscillation and Lipid Metabolism in a Mouse Model.

The Mechanism of Oral Melatonin Ameliorates Intestinal and Adipose Lipid Dysmetabolism Through Reducing Escherichia Coli-Derived Lipopolysaccharide.

Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high‐fat diet‐fed mice

Melatonin: a Novel Strategy for Prevention of Obesity and Fat Accumulation in Peripheral Organs Through the Improvements of Circadian Rhythms and Antioxidative Capacity

Melatonin Prevents Obesity Through Modulation of Gut Microbiota in Mice.

Administration of Exogenous Melatonin Improves the Diurnal Rhythms of the Gut Microbiota in Mice Fed a High-Fat Diet

Homeostatic crosstalk among gut microbiome, hypothalamic and hepatic circadian clock oscillations, immunity and metabolism in response to different light-dark cycles: A multiomics study

Mechanisms of Melatonin in Obesity: A Review

Obesity alters circadian and behavioral responses to constant light in male mice

Circadian rhythms and obesity: Timekeeping governs lipid metabolism

Melatonin-mediated corrective changes in gut microbiota of experimentally chronodisrupted C57BL/6J mice

Melatonin Promotes Circadian Rhythm-Induced Proliferation Through Clock/Histone Deacetylase 3/C-Myc Interaction in Mouse Adipose Tissue

Effects of altered photoperiod on circadian clock and lipid metabolism in rats.

Melatonin improves the homeostasis of mice gut microbiota rhythm caused by sleep restriction

Melatonin restores hepatic lipid metabolic homeostasis disrupted by blue light at night in high‐fat diet‐fed mice

Melatonin Alleviates Liver Mitochondrial Dysfunction in Leptin-Deficient Mice

Melatonin Reduces Intramuscular Fat Deposition by Promoting Lipolysis and Increasing Mitochondrial Function.

Melatonin Improves Non-Alcoholic Fatty Liver Disease Via MAPK-JNK/P38 Signaling in High-Fat-diet-induced Obese Mice

Circadian-independent light regulation of mammalian metabolism

Light modulates glucose and lipid homeostasis via the sympathetic nervous system